Viatris Inc. Common Stock (VTRS)

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

Industry: Pharmaceutical Preparations (SIC 2834)

Market region: US

Address: 1000 Mylan Boulevard, Canonsburg, PA, 15317

Market capitalization

21.86 billion USD (21,863,427,096 USD)

Listing date

02/23/1973

Weighted shares outstanding

1,148,590,864

Share class shares outstanding

1,148,590,864

https://www.viatris.com